Alamar Biosciences, Inc. · NASDAQ:ALMR
Nicholas Naclerio bought 235,294 Alamar Biosciences, Inc. shares (Form 4)
Traded Apr 20, 2026 · Filed Apr 20, 2026
On Apr 20, 2026, Nicholas Naclerio (Director) bought 235,294 Alamar Biosciences, Inc. shares at US$17.00 for US$4M, leaving 5,686 shares. Filed Apr 20, 2026 (Form 4).
- Bought
- 235,294 shares
- Price
- US$17.00
- Value
- US$4M
- Holding after
- 5,686 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 20, 2026 | Class B Common Stock | Conversion | 4,588,364 | 4,588,364 | Indirect | |
| Apr 20, 2026 | Class B Common Stock | Conversion | 922,152 | 5,510,516 | Indirect | |
| Apr 20, 2026 | Class B Common Stock | Other | 5,510,516 | 0 | Indirect | |
| Apr 20, 2026 | Common Stock | Conversion | 346,020 | 5,856,536 | Indirect | |
| Apr 20, 2026 | Common Stock | Conversion | 271,782 | 271,782 | Indirect | |
| Apr 20, 2026 | Common Stock | Buy | 235,294 | US$17.00 | 507,076 | Indirect |
| Apr 20, 2026 | Common Stock | Award | 5,686 | 5,686 | Direct |